Research on HER2 expression in metastatic colorectal cancer
Not Applicable
- Conditions
- Colorectal cancer
- Registration Number
- JPRN-UMIN000018786
- Lead Sponsor
- Japan Clinical Cancer Research Organization
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients who received neoadjuvant chemotherapy . (2) Patients who are regarded as inadequate for study enrollment by investigators.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The HER2-positive ratio by the IHC method, the FISH method and the HERmark method
- Secondary Outcome Measures
Name Time Method To evaluate the sensitivity of the HERmark method. To examine the relationship between the HER2 expression and the background factor.